39 Results for "

Histone phosphorylation

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "Histone phosphorylation" in MCE Product Catalog:

34
34 Publications Verification
Cat. No.: HY-B0350A
CAS No.: 156-54-7
Synonyms: Butanoic acid sodium; Butyric acid sodium
Target:  

HDAC

Sodium butyrate ((Butanoic acid; Butyric acid) sodium) is an orally active HDAC inhibitor. Sodium butyrate induces hyperacetylation of core histones and affects phosphorylation of H1/H2A, thereby altering chromatin structure and regulating gene expression. Sodium butyrate can be used in research related to various cancers, inflammatory bowel disease, and sickle cell anemia .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-16305
CAS No.: 176161-24-3
Synonyms: 1263W94; BW1263W94; GW257406X
Target:  

EBV CMV

Research Areas:  

Infection

Maribavir is a potent inhibitor of histone phosphorylation catalyzed by wild-type pUL97 in vitro, with an IC50 of 3 nM. Maribavir has potent antiviral activity against HCMV and Epstein-Barr virus (EBV).
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-123834
CAS No.: 824983-91-7
Purity:  99.85%
Target:  

FLAP ATM/ATR

Research Areas:  

Cancer

FEN1-IN-1 (compound 1) is a small molecule flap endonuclease 1 (FEN1) inhibitor with antitumor activity. FEN1-IN-1 binds to the active site of FEN1 and partly achieves inhibition by the co-ordination of Mg 2+ ions. FEN1-IN-1 initiaties a DNA damage response and activates the ATM checkpoint signalling pathway, the phosphorylation of histone H2AX and the ubiquitination of FANCD2 in mammalian cells. FEN1-IN-1 is promising for research of cancers .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-15217
CAS No.: 1333377-65-3
Purity:  96.71%
Target:  

Haspin Kinase

Research Areas:  

Cancer

CHR-6494 is a potent inhibitor of haspin, with an IC50 of 2 nM. CHR-6494 inhibits histone H3T3 phosphorylation. CHR-6494 can be used in the research of cancer .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-12037A
CAS No.: 592542-59-1
Purity:  99.01%
Synonyms: ON-01910
Research Areas:  

Cancer

Rigosertib (ON-01910) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3 kinase/Akt pathway, promots the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle . Rigosertib is a selective and non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-12037
CAS No.: 592542-60-4
Purity:  99.57%
Synonyms: ON-01910 sodium
Rigosertib sodium (ON-01910 sodium) is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition the PI3K/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in cell cycle . Rigosertib sodium is a selective and non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-141539
CAS No.: 2755823-12-0
Purity:  99.93%
Research Areas:  

Cancer

SETDB1-TTD-IN-1 is a SETDB1 methyltransferase activator and SETDB1-TTD competitive inhibitor (Kd of 88 nM), and selectivity for SETDB1-TTD over other tudor and bromodomain proteins. SETDB1-TTD-IN-1 stimulates methyltransferase activity via increased catalytic activity, promotes Akt1 Lys64 methylation, Akt1 Thr308 phosphorylation and activation. SETDB1-TTD-IN-1 prevents SETDB1-TTD-histone H3 peptide association, induces global gene expression changes, exhibits cellular target engagement, and acts as a tool compound for SETDB1-TTD function exploration. SETDB1-TTD-IN-1 can be used for the research of breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117709
CAS No.: 1404562-17-9
Purity:  98.90%
BRD6688 is a selective HDAC inhibitor with IC50 values of 21 nM and 100 nM for HDAC1 and HDAC2, respectively. BRD6688 induces histone H4K12 and H3K9 acetylation. BRD6688 decreases CK2-induced HDAC2 phosphorylation. BRD6688 induces macrophage M1 to M2 polarization and renal cell proliferation. BRD6688 is used in research on neurodegenerative diseases, acute kidney injury, pain, and anxiety disorders .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-118034
CAS No.: 1110905-26-4
Purity:  99.60%
Target:  

p38 MAPK Apoptosis

Research Areas:  

Cancer

MTBT is an anticancer agent and p38 MAPK activator. MTBT can inhibit tumor cell proliferation, induce cell cycle arrest and apoptosis. MTBT increases the phosphorylation of histone H3 serine in cancer cells, thereby arresting the cell cycle in the M phase. The specific inhibitor of p38 MAPK, Adezmapimod (HY-10256), can abrogate the cell cycle arrest induced by MTBT .
loading...
    loading...
Cat. No.: HY-16305S
Synonyms: 1263W94-d6; BW1263W94-d6; GW257406X-d6
Maribavir-d6 (1263W94-d6) is a deuterium labeled Maribavir (HY-16305). Maribavir is a potent inhibitor of histone phosphorylation catalyzed by wild-type pUL97 in vitro, with an IC50 of 3 nM .
loading...
    loading...
Cat. No.: HY-126249
CAS No.: 2247919-28-2
Purity:  98.31%
Research Areas:  

Cancer

AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, which can cause mitotic delay and arrest cells in a prometaphase, reflecting by the biomarker histone H3 Ser10 phosphorylation and followed by a surge in apoptosis. AAPK-25 targets Aurora-A, -B, and -C with Kd values ranging from 23-289 nM, as well as PLK-1, -2, and -3 with Kd values ranging from 55-456 nM .
loading...
    loading...
Cat. No.: HY-149669
CAS No.: 3053430-96-6
Purity:  99.29%
Research Areas:  

Cancer

PH14 is a PI3Kα/HDAC3 inhibitor, with an IC50 value of 20.3 nM against PI3Kα and 24.5 nM against HDAC3. PH14 blocks the phosphorylation of AKT, inhibits the PI3K/AKT signaling pathway, increases the level of acetylated histone H3, promotes apoptosis, and exerts antiproliferative activity against tumor cells. PH14 can be used in the research of mantle cell lymphoma, myeloma, acute promyelocytic leukemia, and breast cancer .
loading...
    loading...
Cat. No.: HY-172157
CAS No.: 2919766-97-3
Target:  

HDAC AMPK

Research Areas:  

Metabolic Disease

HDAC11-IN-2 (compound B6) is a high selective Histone Deacetylase 11 (HDAC11) inhibitor. HDAC11-IN-2 inhibits HDAC11 and HDAC8 with IC50s of 51.1 ×10 -3 μM and 5 μM, respectively. HDAC11-IN-2 inhibits denovolipogenesis (DNL) and promotes fatty acid oxidation, thus mitigating hepaticlipid accumulation and pathological symptoms in MASLD mice. HDAC11-IN-2 enhances the phosphorylation of AMPKα1 at Thr172 through the inhibition of HDAC11, consequently modulating DNL and fatty acid oxidation in the liver .
loading...
    loading...
Cat. No.: HY-110350
CAS No.: 1458630-17-5
Target:  

Haspin Kinase

Research Areas:  

Cancer

CHR-6494 TFA is a potent inhibitor of haspin, with an IC50 of 2 nM. CHR-6494 TFA inhibits histone H3T3 phosphorylation. CHR-6494 TFA induces the apoptosis of cancer cells, including melanoma and breast cancer. CHR-6494 TFA can be used in the research of cancer .
loading...
    loading...
Cat. No.: HY-162616
CAS No.: 1225038-92-5
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

SelSA is a selective, orally active inhibitor for histone deacetylase 6 (HDAC6) with IC50 of 56.9 nM. SelSA inhibits the phosphorylation of ERK1/2. SelSA inhibits the proliferation of breast cancer cells and hepatocellular carcinoma cells with IC50 of 0.58-2.6 μM, inhibits cell migration and invasion of Huh7, and induces apoptosis. SelSA exhibits antitumor activity in mouse model .
loading...
    loading...
Cat. No.: HY-176036
CAS No.: 3070323-06-4
MS1262 is a blood-brain barrier-permeable, selective inhibitor of histone methyltransferases G9a (EHMT2) and GLP (EHMT1), with an IC50 of 19 nM and a Kd of 74 nM against G9a, and an IC50 of 6 nM and a Kd of 19 nM against GLP. MS1262 reduces the dimethylation level of histone H3 lysine 9 and decreases the size of Aβ plaques. MS1262 restores hippocampal long-term potentiation (LTP) and miniature excitatory postsynaptic current (sEPSC) frequency, ameliorates spatial memory deficits, and reverses anxiety-like and depression-like behaviors in AD model mice. MS1262 reverses the expression/phosphorylation levels of early AD biomarkers, providing support for stage-specific diagnosis of AD. MS1262 reduces the risk of thrombus rupture. MS1262 can be used in research related to Alzheimer's disease, colorectal cancer, and triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-P5988
CAS No.: 152246-40-7
Target:  

PKC

Research Areas:  

Cancer

N-myristoyl-RKRTLRRL inhibits binding of PKC substrates. N-myristoyl-RKRTLRRL inhibits Ca 2+- and phosphatidylserine (PS)-dependent histone phosphorylation with IC50 of 5 μM. histone phosphorylation with IC50 of 80 μM .
loading...
    loading...
Cat. No.: HY-16305R
CAS No.: 176161-24-3
Synonyms: 1263W94 (Standard); BW1263W94 (Standard); GW257406X (Standard)
Research Areas:  

Infection

Maribavir (Standard) is the analytical standard of Maribavir. This product is intended for research and analytical applications. Maribavir is a potent inhibitor of histone phosphorylation catalyzed by wild-type pUL97 in vitro, with an IC50 of 3 nM. Maribavir has potent antiviral activity against HCMV and Epstein-Barr virus (EBV).
loading...
    loading...
Cat. No.: HY-P3745
CAS No.: 65189-70-0
Target:  

PKA

Research Areas:  

Others

H1-7 (histone H1 phosphorylation site), PKA Substrate, a synthetic polypeptide, can be used as PKA substrate .
loading...
    loading...
Cat. No.: HY-125090
CAS No.: 398493-74-8
PHA-680626 is an effective inhibitor of the interaction between Aurora-A and N-Myc. PHA-680626 inhibits kinase activity of AURKA and Bcr-Abl, and induces N-Myc degradation. PHA-680626 decreases phosphorylation of CrkL and histone H3. PHA-680626 shows anti-proliferative and pro-apoptotic activity on Imatinib (HY-15463)-resistant chronic myeloid leukemia cell lines and primary CD34+ cells .
loading...
    loading...